These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21755834)

  • 21. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
    Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic utility of procalcitonin in community-acquired respiratory tract infections--a literature review].
    Wróblewski T; Marcisz C; Kurzawska G
    Postepy Hig Med Dosw (Online); 2004; 58():495-505. PubMed ID: 15765011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples.
    Kremmer E; Meyer K; Grässer FA; Flatley A; Kösters M; Luppa PB; Krämer PM
    Anal Bioanal Chem; 2012 Jan; 402(2):989-95. PubMed ID: 22006244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in China.
    Wang H; Wang H; Chen S; Dzakah EE; Kang K; Wang J; Wang J
    Clin Chim Acta; 2015 Apr; 444():37-42. PubMed ID: 25659293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin measurement for detection of serious bacterial infection in febrile children: comparison between two automated immunoassays.
    Lacroix L; Manzano S; Galetto A; Gervaix A
    Clin Biochem; 2012 May; 45(7-8):593-5. PubMed ID: 22386955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin kinetics in Legionella pneumophila pneumonia.
    de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC
    Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of procalcitonin in ventilator associated pneumonia].
    Zhou CD; Lu ZY; Ren NZ; Zhang GC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jun; 18(6):370-2. PubMed ID: 16784569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of bacterial infection using procalcitonin].
    Takajo I; Okayama A
    Rinsho Byori; 2010 May; 58(5):517-22. PubMed ID: 20560461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C
    Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of procalcitonin concentration in clinical diagnosis].
    Czerwionka-Szaflarska M; Parzecka M
    Pol Merkur Lekarski; 2005 Oct; 19(112):584-6. PubMed ID: 16379332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.
    Don M; Valent F; Korppi M; Falleti E; De Candia A; Fasoli L; Tenore A; Canciani M
    Scand J Infect Dis; 2007; 39(2):129-37. PubMed ID: 17366029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A; Binder L; Clough M; Hernandez MH; Lefèvre G; Mostert K; Nguyen TB; Otte KM; Portakal O; Sandri MS; Yen JL; Huang J; Beshiri A
    Pract Lab Med; 2018 Nov; 12():e00110. PubMed ID: 30519621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.